OK Biotech Co., Ltd. (TPE:4155)
13.45
+0.05 (0.37%)
Apr 20, 2026, 1:21 PM CST
OK Biotech Company Description
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe.
The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips.
It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services.
The company sells its products under the OKB and Prodigy brands. OK Biotech Co., Ltd. was incorporated in 2004 and is headquartered in Hsinchu City, Taiwan.
Contact Details
Address: No. 91, Gongdao 5th Road Hsinchu City, 30070 Taiwan | |
| Phone | 886 3 516 0258 |
| Website | okbiotech.com |
Stock Details
| Ticker Symbol | 4155 |
| Exchange | Taiwan Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004155007 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Jia-De Lai | General Manager, MD and Chairman of the Board |
| Qi Zheng Hou | Chief Financial Officer, Financial Manager and Accounting Supervisor |
| De Quan Zhang | Chief Operating Officer and Deputy GM |
